One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v130.suppl_1.498.498
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Jun 25, 2021 |
 Citations: 4 |
Affiliation: The Ohio State University, Hofstra University, Dana-Farber Cancer Institute, Vifor Pharma (United States), University of Oxford, Vita-Salute San Raffaele University, Istituti di Ricovero e Cura a Carattere Scientifico, The University of Texas MD Anderson Cancer Center, Northwest Medical Specialties, New York Hospital Queens, NewYork–Presbyterian Hospital, Presbyterian Hospital, King's College Hospital, Huntsman Cancer Institute, University of Utah, St James's University Hospital
Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Updated Results from the Phase 1/2 ACE-CL-001 Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
